Altimmune, Inc.
ALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326190
In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Altimmune, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +11 vs. Q2 2022
- Shares held
- 46.0M
- +6.14M (+15.4%) vs. Q2 2022
- Total value
- $588.1M
- +$121.2M (+26.0%) vs. Q2 2022
- New holders
- 40
- 39 more added
- Sold out
- 29
- 27 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 210 | $456.1M |
| Q1 2026 | 173 | $213.5M |
| Q4 2025 | 183 | $198.8M |
| Q3 2025 | 159 | $156.4M |
| Q2 2025 | 180 | $145.5M |
| Q1 2025 | 177 | $191.2M |
| Q4 2024 | 183 | $292.3M |
| Q3 2024 | 169 | $243.0M |
| Q2 2024 | 173 | $282.1M |
| Q1 2024 | 171 | $452.2M |
| Q4 2023 | 143 | $377.1M |
| Q3 2023 | 113 | $79.2M |
| Q2 2023 | 120 | $124.5M |
| Q1 2023 | 133 | $205.4M |
| Q4 2022 | 128 | $769.9M |
| Q3 2022 | 122 | $588.1M |
| Q2 2022 | 111 | $466.9M |
| Q1 2022 | 103 | $207.4M |
| Q4 2021 | 102 | $295.8M |
| Q3 2021 | 119 | $375.3M |
| Q2 2021 | 109 | $269.2M |
| Q1 2021 | 98 | $336.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Altimmune, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 600,298 | $7.67M | 1.36% | −792,586−56.9% | Reduced |
| JPMorgan Chase & Co | 651,028 | $8.31M | 0.00% | +490,455+305.4% | Added |
| Goldman Sachs Group Inc | 735,744 | $9.39M | 0.00% | +230,988+45.8% | Added |
| Logos Global Management LP | 750,000 | $9.58M | 1.18% | +750,000 | New |
| Laurion Capital Management LP | 750,105 | $9.58M | 0.27% | −13,865−1.8% | Reduced |
| Two Sigma Advisers, LP | 868,800 | $11.1M | 0.03% | +102,200+13.3% | Added |
| Ardsley Advisory Partners LP | 927,950 | $11.8M | 3.13% | −411,050−30.7% | Reduced |
| Two Sigma Investments, LP | 977,647 | $12.5M | 0.04% | +362,029+58.8% | Added |
| Renaissance Technologies LLC | 998,200 | $12.7M | 0.02% | +332,800+50.0% | Added |
| Woodline Partners LP | 1,018,091 | $13.0M | 0.19% | +467,406+84.9% | Added |
| Balyasny Asset Management LLC | 1,037,662 | $13.3M | 0.05% | +831,193+402.6% | Added |
| Marshall Wace, LLP | 1,098,914 | $14.0M | 0.04% | +828,584+306.5% | Added |
| BlackRock Inc. | 1,219,300 | $15.6M | 0.00% | +257,116+26.7% | Added |
| Driehaus Capital Management LLC | 1,222,586 | $15.6M | 0.24% | +282,525+30.1% | Added |
| Baker Bros. Advisors LP | 1,769,681 | $22.6M | 0.15% | −305,722−14.7% | Reduced |
| Vanguard Group Inc | 2,027,042 | $25.9M | 0.00% | +301,496+17.5% | Added |
| Tang Capital Management LLC | 2,600,450 | $33.2M | 4.07% | −1,000,000−27.8% | Reduced |
| Avidity Partners Management LP | 2,684,000 | $34.3M | 0.75% | −297,000−10.0% | Reduced |
| Nuveen Asset Management, LLC | 3,213,900 | $41.0M | 0.02% | +149,620+4.9% | Added |
| State Street Corp | 3,398,856 | $43.4M | 0.00% | +3,263,310+2,407.5% | Added |
| Cormorant Asset Management, LP | 3,442,863 | $44.0M | 3.09% | +442,863+14.8% | Added |
| Janus Henderson Group PLC | 4,121,814 | $52.6M | 0.04% | +4,121,814 | New |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −609,100−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −559,755−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −411,039−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −350,526−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −305,879−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −214,700−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −189,600−100.0% | Sold out |
| Timelo Investment Management Inc. | 0 | $0 | 0.00% | −187,529−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −169,683−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −134,993−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −98,659−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −68,400−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −53,294−100.0% | Sold out |
| Prescott General Partners LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −35,939−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −28,133−100.0% | Sold out |
| Apollon Wealth Management, LLC | 0 | $0 | 0.00% | −26,483−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −19,543−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −17,875−100.0% | Sold out |
| King Wealth | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Emfo, LLC | 0 | $0 | 0.00% | – | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −2,730−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −282−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Providence Capital Advisors, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Curi Capital | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |